Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Primary hyperparathyroidism: systematic post-surgical treatment with strontium ranelate and calcium/vitamin D
2008-001703-32Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of strontium ranelate in primary hyperparathyroidism (PHPT), osteopenia and osteoporosis, sponsored by Medical University of Vienna. Primary endpoints: Change in bone mineral density and Changes in bone and calcium metabolism markers. Started Aug 2010; status: completed.
02
Drugs
strontium ranelate
03
Conditions
primary hyperparathyroidism (PHPT)osteopeniaosteoporosis
Beyond the preview
Go deeper on 2008-001703-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001703-32.